Table 3.
Pattern of antimicrobial resistance in Pseudomonas aeruginosa in association with departments.
| Antibiotic | Wards | |||||||
|---|---|---|---|---|---|---|---|---|
| Surgery | Medicine | Orthopaeds | ICU | ENT | Gynaecology | Total | p-value* | |
| Meropenem | 56 | 42 | 4 | 14 | 8 | 6 | 130 (51%) | 0.000 |
| Imipenem | 62 | 27 | 21 | 9 | 7 | 9 | 135 (53%) | 0.005 |
| Gentamicin | 51 | 44 | 25 | 10 | 4 | 6 | 140 (55%) | 0.001 |
| Cefoxitin | 43 | 30 | 10 | 24 | 2 | 5 | 114 (45%) | 0.000 |
| Ciprofloxacin | 51 | 51 | 22 | 8 | 4 | 4 | 140 (55%) | 0.000 |
| Ceftazidime | 65 | 35 | 16 | 14 | 10 | 13 | 153 (60%) | 0.062 |
| Aztreonam | 39 | 32 | 28 | 18 | 5 | 6 | 128 (50%) | 0.001 |
| Pip-Tazo | 35 | 25 | 19 | 16 | 3 | 4 | 102 (40%) | 0.048 |
| Amikacin | 51 | 35 | 5 | 9 | 5 | 10 | 115 (45%) | 0.001 |
| Cefoperazone-Sulbactam | 76 | 39 | 11 | 10 | 5 | 7 | 148 (58%) | 0.000 |
Vertical ranking enlists antibiotics. Horizontal ranking enlists the department of sample collection.
*p value ≤ 0.05 was considered statistically significant.